GSK Investigational Site

Grapevine, Texas 76051

0 studies enrolling now · 3 studies all time

What they study most

Diabetes Mellitus, Type 2, Lung Cancer, Non-Small Cell, Respiratory Syncytial Virus Infections

Studies at this site

• A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers — Stopped early
• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. — Completed